Home / Contact / Sitemap / Disclaimer
ABOUT US
PERSONALIZED MEDICINE
& CNS
PRODUCTS & TECHNOLOGY
BUSINESS DEVELOPMENT
INVESTORS
MEDIA
   
Financial Reports
Constitutional Documents
RNS Announcements
Share Details
Share Price
Analyst Coverage
Committees
Company Overview
Board of Directors
Advisers
 
 
Curidium Medica plc trades on the LSE: AIM
AIM symbol: CUR
ISIN number: GB0033550863
Registrars: Capita Registrars
The Registry
34 Beckenham Road
Beckenham
Kent , BR3 4TU
Curidium's securities are not traded on any other exchanges or trading platforms besides AIM.


13 Oct 2008
Authorised: Number  
Ordinary shares of 3p each 28,666,666  
Deferred shares of 24p each 40,000,000  
Deferred shares of 0.9p each 60,000,000  
Total 128,666,666  
 
Allotted, called up
and fully paid:
Number % Not in public hands
Ordinary shares of 3p each 18,943,439 24.41%
Deferred shares of 24p each 17,866,670 0%
Deferred shares of 0.9p each 35,405,696 0%
Total 72,215,805  




Major share holders (as at 13 October 2008):
Shareholder Number of shares Percentage of issued share capital
Gartmore Investment Management 3,805,999 20.091%
Dr A Bruinvels 3,089,282 16.31%
Bainunah Trading Limited 2,558,225 13.50%
OCS Trading Ltd 1,929,999 10.10%
Dr. Barry Porter 1,013,501 5.35%
Eleonora International Inv LTD 832,217 4.39%
Williams De Broe 750,500 3.96%
Mr. Michael Underwood 709,188 3.74%

There are no restrictions on transfer of securities

Curidium Medica plc © 2006-2008 | Email: info@curidium.com Tel.: +44 (0)20 7554 5100
This site was last updated on 13.10.08